Charles River Laboratories | CRL - Assets

Stock Price
173.89
Daily Change
-1.01 -0.58%
Monthly
-1.02%
Yearly
23.34%
Q2 Forecast
168.66

Charles River Laboratories reported $7.14B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Agilent USD 12.81B 86M Dec/2025
Align Technology USD 6.23B 141K Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Cardinal Health USD 58.08B 2.86B Dec/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Cigna USD 157.92B 0 Dec/2025
Concord Medical Services Hldg CNY 6.73B 663.4M Jun/2025
CVS Health USD 253.54B 1.79B Dec/2025
Danaher USD 83.46B 3.57B Dec/2025
Dentsply International USD 5.43B 224M Dec/2025
Elevance Health USD 121.49B 1.26B Dec/2025
Galapagos EUR 3.41B 105.39M Dec/2025
Hologic USD 9.18B 165.8M Dec/2025
Humana USD 48.91B 810M Dec/2025
Illumina USD 6.64B 467M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
Intrexon USD 73.16M 77.88M Jun/2024
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Laboratory Of America USD 18.39B 131.1M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
McKesson USD 84.19B 30M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Mettler Toledo International USD 3.71B 191.18M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Quest Diagnostics USD 16.23B 28M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
United Therapeutics USD 7.88B 528.9M Dec/2025
UnitedHealth USD 309.58B 5.69B Dec/2025
Veradigm USD 1.5B 185.94M Dec/2022
Waters USD 5.08B 221.41M Dec/2025
West Pharmaceutical Services USD 4.27B 164.2M Dec/2025